期刊文献+

基因检测指导1例溴鼠灵中毒个体化治疗

Individualized Drug Administration of Brodifacoum Poisoning Under the Guidance of Genetic Detection
原文传递
导出
摘要 目的利用基因检测技术指导溴鼠灵中毒患者个体化用药。方法采静脉血2 mL提取核酸,荧光原位杂交(FISH)测定VKORC1(rs99223231)和CYP2C9*3(rs1057910)基因,根据结果为患者提供个体化用药建议。结果患者VKORC1基因型为AA,正常代谢型,CYP2C9*3基因型为AA,溴鼠灵敏感型,用药方案调整后,患者的病情稳定,无不良反应发生。结论基因检测指导患者溴鼠灵中毒时维生素K1个体化给药,可以促进合理用药。 OBJECTIVE To guide the individualized administration of brodifacoum poisoning by genetic testing.METHODS DNA was extracted from 2 mL venous blood,Fluorescencein situ hybridization analysis was used for the VKORC1(rs9923231) and CYP2C9*3(rs1057910) genotype,and the individual recommendations were provided for the patients according to genotype.RESULTS The VKORC1 genotype of the patient was AA,indicating normal metabolic type,and the CYP2C9*3 genotype was AA,indicating sensitive type of brodifacoum.After the adjusting of the medication plan to the patient genotype,the patient's condition remained stable and no adverse reactions occurred.CONCLUTION Genetic testing can guide the individualized administration of vitamin K1 when patients are poisoned by brodifacoum,which can promote rational drug use.
作者 许启荣 郭秀彩 陈纠 杨志前 张紫萍 XU Qirong;GUO Xiucai;CHEN Jiu;YANG Zhiqian;ZHANG Ziping(Drug Clinical Trial Institution,Guangzhou Twelfth People's Hospital,Guangzhou,Guangdong 510620,China;Central Laboratory,Guangzhou Twelfth People's Hospital,Guangzhou,Guangdong 510620,China;Department of Occupational Disease,Guangzhou Twelfth People's Hospital,Guangzhou,Guangdong 510620,China)
出处 《今日药学》 CAS 2024年第1期64-66,共3页 Pharmacy Today
关键词 VKORC1 CYP2C9 基因检测 溴鼠灵 维生素K1 VKORCl CYP2C9 genetic test brodifacoum vitamin K,
  • 相关文献

参考文献6

二级参考文献49

  • 1李道中.溴敌隆对非靶动物的毒性及二次中毒[J].中国鼠类防制杂志,1989,5(2):117-119. 被引量:5
  • 2施爱民,程健,顾军,钟义红.抗凝血杀鼠剂溴敌隆的亚慢性毒性试验[J].毒理学杂志,2007,21(1):79-80. 被引量:6
  • 3Hong J, Yhim HY, Bang SM, et al. Korean patients with superwarfarin intoxication and their outcome [J]. J Korean Med Sci, 2010, 25 (12): 1754-1758.
  • 4Lubetsky A, Yonath H, Olchovsky D, et al. Compari- son of oral vs intravenous phytonadione (vitamin K1) in patients with excessive anticoagulation: a prospective randomized controlled study[J]. Arch Intern Med, 2003, 163 (20): 2469-2473.
  • 5Schulman S, Furie B. How I treat poisoning with vit- amin K antagonists[J]. Blood, 2015, 125 (3): 438-442.
  • 6Park J. Can we more efficiently save patients with vi- tamin K-dependent coagulopathy caused by superwarfarin intoxication [J]. Korean J Intern Med,2014, 29 (4): 430-433.
  • 7Palmer RB, Alakija P, de Baca JE, et al. Fatal bro- difaeoum rodenticide poisoning: autopsy and toxicologic findings[J]. J Forensic Sci, 1999, 44 (4): 851-855.
  • 8Hollinger BR, Pastoor TP. Case management and pla- sma half-life in a case of brodifacoum poisoning [J]. Arch Intern Med, 1993, 153 (16): 1925-1928.
  • 9Lee H J, You MR, Moon WR, et al. Evaluation of risk factors in patients with vitamin K-dependent coagulopathy presumed to be caused by exposure to brodifacoum [J]. Korean J Intern Med, 2014, 29 (4): 498-508.
  • 10Spahr JE, Maul JS, Rodgers GM. Superwarfarin poi- soning: a report of two cases and review of the literature[J]. Am J Hematol, 2007, 82 (7): 656-660.

共引文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部